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INTRODUCTION 
Oral Submucous Fibrosis (OSMF) has a well-
known history, as it was known by Sushruta, one 
on India’s great physicians as ‘Vidari’.1,2  This 
condition is predominantly found in the Indian 
subcontinent. Joshi in 1953 was the first person to 
describe this entity in India.3 Oral Submucous 
Fibrosis is one of the most poorly understood and 
unsatisfactorily treated diseases with risk of 
malignant change in advanced cases of OSMF 
being 3 to 6%.  
 
JJ Pindborg defined it as “an insidious chronic 
disease affecting any part of the oral cavity and 
sometimes the pharynx. Although occasionally 
preceded by and /or associated with vesicle 
formation, it is always associated with juxta 
epithelial inflammatory reaction followed by a 
fibro elastic change of lamina propria, with 
epithelial atrophy leading to stiffness of oral 
mucosa and causing trismus and inability to eat”.4 
The onset of the condition is insidious and the 
most    common     initial    symptom   is    burning  
 
sensation experienced on eating spicy hot food or 
on intake of hot beverages. Early signs are blisters, 
ulcerations or recurrent stomatitis. Excessive 
salivation, defective gustatory sensation, 
regurgitation and nasal resonance are rarely 
encountered. Restricted tongue movements are 
seen in advanced cases. The buccal mucosa, 
retromolar areas, soft palate and lips are 
commonly affected by OSMF. An occasional 
involvement of the pharynx and oesophagus is 
seen in some cases .5 
 
There is no definite treatment for this condition. 
The various treatment modalities are mainly 
medical, surgical, or a combination of both with 
conservative/medical modality being the 
treatment of choice in patients having mild to 
moderate limitation(s) in opening their mouth. 
The Conservative, medical line of treatment 
includes usage of gold,6 iodides, hyluronidase, 
placental extract, and steroids (hydrocortisone, 
triamcinolone), iron  in the  form  of supplements  
 
 
 
AIM: To evaluate the efficacy of Low Level Laser Therapy (LLLT) in treatment of Oral Submucous Fibrosis (OSMF). 
 
MATERIAL & METHODS: 20 patients with a clinical diagnosis of OSMF were included in the study after informed consents and 
measurements of mouth opening (mm) and burning sensation (VAS) were made at day 0. Laser biostimulation was performed on 
right and left cheeks in anterior and posterior bands for 3 cycles of 10 seconds each. They were recalled for follow-up measurements 
and laser biostimulation at 3rd, 7th and 15th day. The paired t-test was applied for analysing significant differences, if any, using SPSS 
version 21.0. 
 
RESULTS: In the follow up recordings, generally, there was an increase in mouth opening after LLLT therapy and a significant 
difference was seen in males(p=.04) as well as the total population(p=0.02). Burning sensation(VAS Scale), on day zero was 5.5±1.20, 
which was reduced to 3.4±.084 on the 15th day with a significant difference seen in the entire study population(p=0.03). 
 
CONCLUSION: Biostimulation by laser in the treatment of OSMF is a good non-invasive, painless and quick alternative treatment 
modality for the management of the diseases.  
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In patients having marked limitation in opening 
his/her mouth, or failure to respond to the 
conservative management leads to surgical 
treatment of the lesion with dermal graft, tongue 
flap, nasolabial flap, Split Skin Graft (SSG) 
followed by Post-operative oral physiotherapy, 
dietary supplementation and other medications 
being routinely done in a dental setting.8 
 
The word ‘LASER’ is an acronym for ‘Light 
Amplification by Stimulated Emission of 
Radiation’. Low-level laser therapy (LLLT) is also 
known as ‘soft laser therapy’ or bio-stimulation. 
The output for a low level laser device which is 
used for this therapy is in the order of 0.1 - 0.6 
watts and is found to be quite effective.9 Laser has 
quite a few advantages as it provides better 
inflammatory responses with reduced oedema, 
pain reduction coupled with cellular 
biostimulation, as compared to current tissue 
regeneration modalities that present increased 
pain and inflammatory responses.10 
 
Based on the above mentioned rationale, the 
present study was conducted with the aim of 
assessing the efficacy of LLLT in treatment of Oral 
Submucous fibrosis among patients visiting a 
dental setting in Greater Noida. The parameters 
which were assessed for evaluating the efficacy 
were limited mouth opening and burning 
sensation.  
 
MATERIALS AND METHODS 
 A total of 20 patients, each with clinically proven 
Oral Submucous Fibrosis, were included in the 
study. Exclusion criteria included patients who 
were already undergoing treatment for Oral 
Submucous Fibrosis, patients with 
Couagulopathies, Blood Disorders, Parkinson’s 
disease and Heart Disease. Ethical Clearance was 
duly taken from the Institutional Review Board, 
I.T.S. Dental College, Hospital and Research 
Centre, Greater Noida. Each patient was informed 
about the procedure and technique, and his/her 
written consent was obtained after duly explaining 
the study protocol.   
 
Pre-procedural evaluations were conducted for 
the following parameters in Oral Submucous 
Fibrosis: 
1. Burning Sensation- Using Visual Analogue 
Scale (VAS). 
2. Mouth Opening– Using Metric Vernier Caliper 
& ‘O’ Scale. 
 
The laser unit which was utilized in the current 
study was ‘Photon Plus Diode Laser’ (Zolar 
Technology and mfg. Co., Canada) which was duly 
calibrated prior to the commencement of the 
study (Figure 1).  The laser unit was set at an 
output power of 0.8 W and a wavelength of 980 
nm. Prior to starting with LLLT, the patient was 
seated comfortably on the dental chair and 
protective eyewear was adorned by the patient, 
the dentist and the assistant. (Figure 3) The 
treatment consisted of four sittings i.e. Day 0, 3, 7 
& 15. 
 
Each sitting consisted of three cycles of low level 
laser applications, each cycle for 10-15 Seconds 
with a gap of about 20-30 seconds between each 
cycle, for a total laser application time of about 
three minutes. The application of the Laser was 
done in the non-contact mode with a distance of 
2-3 cm between the Laser tip and the fibrous band 
surface/ mucosal surface. 
 
The laser beam was applied in a continuous 
sweeping, circular motion, so as to cover the lesion 
surface. Precautions were taken to prevent 
overheating of the mucosa and /or tissue surface, 
which were; a 20-30 seconds gap after each cycle, 
the continuous sweeping motion of the laser beam 
and the 2-3 cm distance between the laser tip and 
mucosal surface.  
 
The burning sensation scores (using VAS) and 
mouth opening (Figure 4) were evaluated 
immediately post the laser applications, at day 
zero, 3, 7 and 15th day.  The patients were asked to 
refrain from using any medications for OSMF 
treatment over the next 15 days.  Also, the patients 
were asked to keep a record of any post procedural 
adverse effects, such as a burning sensation, pain, 
bleeding, etc over the next 15 days. 
 
The responses of the patients were then captured 
into Microsoft excel, and then duly transferred to 
Statistical Package for Social Sciences (SPSS) 
version 21.0 for further analysis.11 After applying 
descriptive statistics, the data was analysed     
using      paired     t-test.       Statistical  significance          
was          set        as            p≤.05.  
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RESULTS 
The present study, with the aim of assessing the 
efficacy of LLLT in treatment of Oral Submucous 
fibrosis enrolled 20 patients, out of which 8(40%) 
were females and 12 were males (60%)(Figure 2).  
 
Table 1. depicts the differences in mouth opening 
before and after LLLT therapy at 0, 3rd, 7th and 
15th day. It was observed that generally, there was 
an increase in mouth opening after LLLT therapy 
and a significant difference was seen in 
males(p=.04) as well as the total 
population(p=.02). 
 
Upon comparison of the burning sensation based 
on the VAS Scale, it was again observed that there 
was a decreased burning sensation experience by 
the entire study population, as on day zero, it was 
5.5±1.20, which was reduced to 3.4±.084 on the 
15th day. A significant difference was seen among 
the entire study population (p=.03)(Table 2) 
 
DISUSSION 
As compared to broadband light sources, lasers 
emit coherent, monochromatic, and collimated 
electromagnetic radiation with high intensity and 
display a high optical power per unit area for a 
given amount of energy, and hence, give laser the 
opportunity to be applied in both medical and 
dental field with unique applications.12 
 
In the present study, the use of laser for treatment 
of OSMF vas found to be quite beneficial for the 
study subjects, with a reduction in pain and 
increased mouth opening. Such results are 
supported by findings of various authors2,12-16 
across the globe who report better mouth 
opening, reduced discomfort and little 
inflammation of the treated lesion, making it a 
preferred treatment modality for treating lesions 
with OSMF. 
 
CONCLUSION 
A variety of treatment modalities for treatment of 
OSMF are easily available and are strongly 
supported by various authors, with each modality 
having its own pros and cons. However,  there is 
still no universally acceptable protocol for the 
management of OSMF as the etiology of the 
disease is not fully understood.2 The results of the 
present study support the fact that laser treatment  
 
 
is an acceptable, and a less painful method of 
treating OSMF with excellent results.  
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LEGENDS 
Figure 1. Diode laser unit used for LLLT 
Laser Biostimulation in Treatment  of OSMF                                                                                                                                 Singh K et al.                                                                                                                                                                                                   
Arora V et al. 
  
12, 60%
8, 40%
n=20
Males Females
Figure 2. Distribution of the study population  
25 
IHRJ Volume 1 Issue 7 2017 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Characteristic Mouth 
Opening at 
0 days(in 
mm) 
(Mean±SD) 
Mouth 
Opening at 
3rd day(in 
mm) 
(Mean±SD) 
Mouth 
Opening at 
7th day(in 
mm) 
(Mean±SD) 
Mouth 
Opening at 
15th day(in 
mm) 
(Mean±SD) 
 
 
p Value  
Males  25.07±1.87 25.85±2.12 26.28±2.01 26.98±2.14 .04* 
Females  22.25±0.83 22.75±0.82 24.10±0.93 24.65±0.86 1.6 
Total  23.94±2.07 24.61±2.29 25.37±2.00 26.05±2.08 0.2* 
Characteristic Burning 
Sensation 
at 0 days 
(in mm) 
(Mean±SD) 
Burning 
Sensation 
at 3rd day 
(in mm) 
(Mean±SD) 
Burning 
Sensation 
at 7th day 
(in mm) 
(Mean±SD) 
Burning 
Sensation 
at 15th day 
(in mm) 
(Mean±SD) 
 
 
p Value  
Males  5.5±0.95 4.83±0.69 4.3±1.00 3.5±0.95 1.1 
Females  5.5±1.5 4.75±0.82 4.25±0.43 3.25±0.43 0.7 
Total  5.5±1.20 4.8±0.74 4.3±0.90 3.4±0.84 0.3* 
Table 1. Differences in Mouth Opening among study subjects 
Table 2. Differences in VAS Score among study subjects 
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Figure 3. Application of LLT therapy Figure 4. Measurement of Mouth Opening 
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